Retinal structure and function preservation by polysaccharides of wolfberry in a mouse model of retinal degeneration

Ke Wang1, Jia Xiao2, Bo Peng1

  • 1Department of Anatomy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong.

Scientific Reports
|December 24, 2014
PubMed

Insights

Wolfberry polysaccharides protect vision in retinitis pigmentosa (RP) mice by preserving photoreceptors. These compounds offer antioxidant, anti-inflammatory, and anti-apoptotic benefits, suggesting future therapeutic potential for RP patients.

Area of Science:

  • Ophthalmology
  • Neuroscience
  • Pharmacology

Background:

  • Retinitis pigmentosa (RP) is an inherited retinal degeneration leading to progressive vision loss.
  • Current treatments for RP are limited, highlighting the need for novel therapeutic strategies.
  • Wolfberry (Lycium barbarum) possesses known ocular health benefits.

Purpose of the Study:

  • To investigate the neuroprotective effects of wolfberry polysaccharides on photoreceptor apoptosis in the rd10 mouse model of RP.
  • To elucidate the underlying mechanisms of action, including antioxidant, anti-inflammatory, and anti-apoptotic pathways.

Main Methods:

  • Administration of wolfberry polysaccharides to rd10 mice.
  • Assessment of photoreceptor morphology and function.
  • Evaluation of visual behavior.
  • Analysis of key molecular markers related to oxidative stress, inflammation (NF-κB), and apoptosis (HIF-1α).

Main Results:

  • Wolfberry polysaccharides significantly preserved photoreceptor structure and function in rd10 mice.
  • Improved visual behaviors were observed in treated rd10 mice.
  • Neuroprotection was mediated by antioxidant, anti-inflammatory, and anti-apoptotic mechanisms, including inhibition of NF-κB and HIF-1α.

Conclusions:

  • Wolfberry polysaccharides demonstrate synergistic protective effects against photoreceptor degeneration in a mouse model of RP.
  • These findings provide a scientific rationale for exploring wolfberry polysaccharides as a supplementary treatment for retinitis pigmentosa.

Related Concept Videos